Download PDF
Semin Respir Crit Care Med 2016; 37(05): 659-669
DOI: 10.1055/s-0036-1592114
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Obstacles to and Solutions for a Successful Lung Cancer Screening Program

Peter J. Mazzone
1   Department of Pulmonary Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

Publication Date:
12 October 2016 (online)

    Permissions and Reprints

Abstract

Lung cancer screening with a low radiation dose chest CT scan has been shown to reduce the number of people, in a well-defined very high-risk cohort, who die from lung cancer. Many potential screening-related harms have been identified, including anxiety and morbidity related to the evaluation of screen-detected findings. A favorable balance of the benefit and harms of lung cancer screening requires careful implementation of a screening program, with a focus on several obstacles to the success of the program. In this review, evidence to support the benefit and harms of lung cancer screening is provided, followed by a discussion of 11 obstacles to the development of a high-quality program. For each obstacle, an approach is suggested, based on evidence and mandates as well as practicality and lessons learned. The approach to each of these obstacles highlights the multi-disciplinary nature of lung cancer screening, and the value of considering lung cancer screening a program rather than a test.

Keywords

lung cancer screening - low-dose chest CT - implementation - quality - lung nodules - smoking cessation
 

  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (1) 7-30
    CrossrefPubMedGoogle Scholar
  • 2 Goldstraw P, Chansky K, Crowley J , et al; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016; 11 (1) 39-51
    CrossrefPubMedGoogle Scholar
  • 3 Patz Jr EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000; 343 (22) 1627-1633
    CrossrefPubMedGoogle Scholar
  • 4 Nash FA, Morgan JM, Tomkins JG. South London lung cancer study. BMJ 1968; 2 (5607) 715-721
    CrossrefPubMedGoogle Scholar
  • 5 Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003; 58 (9) 784-789
    CrossrefPubMedGoogle Scholar
  • 6 Oken MM, Hocking WG, Kvale PA , et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011; 306 (17) 1865-1873
    CrossrefPubMedGoogle Scholar
  • 7 Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS ; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355 (17) 1763-1771
    CrossrefPubMedGoogle Scholar
  • 8 Aberle DR, Berg CD, Black WC , et al; National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011; 258 (1) 243-253
    CrossrefPubMedGoogle Scholar
  • 9 Aberle DR, Adams AM, Berg CD , et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365 (5) 395-409
    CrossrefPubMedGoogle Scholar
  • 10 Church TR, Black WC, Aberle DR , et al; National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013; 368 (21) 1980-1991
    CrossrefPubMedGoogle Scholar
  • 11 Aberle DR, DeMello S, Berg CD , et al; National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013; 369 (10) 920-931
    CrossrefPubMedGoogle Scholar
  • 12 Wille MM, Dirksen A, Ashraf H , et al. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016; 193 (5) 542-551
    CrossrefPubMedGoogle Scholar
  • 13 Infante M, Cavuto S, Lutman FR , et al; DANTE Study Group. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015; 191 (10) 1166-1175
    CrossrefPubMedGoogle Scholar
  • 14 Harris RP, Sheridan SL, Lewis CL , et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014; 174 (2) 281-285
    CrossrefPubMedGoogle Scholar
  • 15 Bach PB, Mirkin JN, Oliver TK , et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012; 307 (22) 2418-2429
    CrossrefPubMedGoogle Scholar
  • 16 van den Bergh KA, Essink-Bot ML, Borsboom GJ , et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010; 102 (1) 27-34
    CrossrefPubMedGoogle Scholar
  • 17 Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer 2015; 121 (24) 4341-4347
    CrossrefPubMedGoogle Scholar
  • 18 Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med 2011; 32 (4) 799-810
    CrossrefPubMedGoogle Scholar
  • 19 Patz Jr EF, Pinsky P, Gatsonis C , et al; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014; 174 (2) 269-274
    Google Scholar
  • 20 Buls N, de Mey J, Covens P, Stadnik T. Health screening with CT: prospective assessment of radiation dose and associated detriment. JBR-BTR 2005; 88 (1) 12-16
    PubMedGoogle Scholar
  • 21 McCunney RJ, Li J. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors. Chest 2014; 145 (3) 618-624
    CrossrefPubMedGoogle Scholar
  • 22 McMahon PM, Kong CY, Bouzan C , et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011; 6 (11) 1841-1848
    CrossrefPubMedGoogle Scholar
  • 23 Black WC, Gareen IF, Soneji SS , et al; National Lung Screening Trial Research Team. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 2014; 371 (19) 1793-1802
    CrossrefPubMedGoogle Scholar
  • 24 http://www.aafp.org/patient-care/clinical-recommendations/all/lung-cancer.html . Accessed May 27, 2016
    PubMed
  • 25 Jacobson FL, Austin JH, Field JK , et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: Recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012; 144 (1) 25-32
    CrossrefPubMedGoogle Scholar
  • 26 Wender R, Fontham ET, Barrera Jr E , et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013; 63 (2) 107-117
    PubMedGoogle Scholar
  • 27 Detterbeck FC, Mazzone PJ, Naidich DF, Bach PB. Screening for lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, Suppl): e78S-e92S
    CrossrefPubMedGoogle Scholar
  • 28 http://www.lung.org/assets/documents/lung-cancer/lung-cancer-screening-report.pdf . Accessed May 27, 2016
    PubMed
  • 29 Roberts H, Walker-Dilks C, Sivjee K , et al. Screening high-risk populations for lung cancer. Available ay: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=287881 . Accessed May 27, 2016
    PubMed
  • 30 https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf . Accessed May 27, 2016
    PubMed
  • 31 Agency for Healthcare Research and Quality. Benefits and harms of computed tomography lung cancer screening programs for high risk populations. Rockville, MD: Agency for Healthcare Research and Quality; 2013. . AHRQ Publication No. 13–05196-EF-2
    Google Scholar
  • 32 Moyer VA ; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160 (5) 330-338
    PubMedGoogle Scholar
  • 33 https://www.cms.gov/medicare-coverage-database/details/medcac-meeting-details.aspx?MEDCACId=68 . Accessed May 27, 2016
    PubMed
  • 34 Mazzone P, Powell CA, Arenberg D , et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015; 147 (2) 295-303
    CrossrefPubMedGoogle Scholar
  • 35 Wiener RS, Gould MK, Arenberg DA , et al; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 2015; 192 (7) 881-891
    CrossrefPubMedGoogle Scholar
  • 36 https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274 . Accessed May 27, 2016
    PubMed
  • 37 Kovalchik SA, Tammemagi M, Berg CD , et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013; 369 (3) 245-254
    CrossrefPubMedGoogle Scholar
  • 38 Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20–29 pack-year smokers: implications for screening. J Natl Cancer Inst 2015; 107 (11) djv226
    CrossrefPubMedGoogle Scholar
  • 39 Bach PB, Kattan MW, Thornquist MD , et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003; 95 (6) 470-478
    CrossrefPubMedGoogle Scholar
  • 40 Spitz MR, Hong WK, Amos CI , et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007; 99 (9) 715-726
    CrossrefPubMedGoogle Scholar
  • 41 Cassidy A, Myles JP, van Tongeren M , et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008; 98 (2) 270-276
    CrossrefPubMedGoogle Scholar
  • 42 Tammemägi MC, Katki HA, Hocking WG , et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368 (8) 728-736
    CrossrefPubMedGoogle Scholar
  • 43 Hoggart C, Brennan P, Tjonneland A , et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila) 2012; 5 (6) 834-846
    CrossrefPubMedGoogle Scholar
  • 44 Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA 2016; 315 (21) 2300-2311
    CrossrefPubMedGoogle Scholar
  • 45 Tammemägi MC, Church TR, Hocking WG , et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014; 11 (12) e1001764
    CrossrefPubMedGoogle Scholar
  • 46 Horeweg N, van der Aalst CM, Thunnissen E , et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013; 187 (8) 848-854
    CrossrefPubMedGoogle Scholar
  • 47 Field JK, Duffy SW, Baldwin DR , et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016; 71 (2) 161-170
    CrossrefPubMedGoogle Scholar
  • 48 Self TH, Wallace JL, Gray LA, Usery JB, Finch CK, Deaton PR. Are we failing to document adequate smoking histories? A brief review 1999-2009. Curr Med Res Opin 2010; 26 (7) 1691-1696
    CrossrefPubMedGoogle Scholar
  • 49 http://www.shouldiscreen.com/ . Accessed May 27, 2016
    PubMed
  • 50 https://www.thoracic.org/patients/patient-resources/resources/decision-aid-lcs.pdf . Accessed May 27, 2016
    PubMed
  • 51 https://effectivehealthcare.ahrq.gov/index.cfm/tools-and-resources/patient-decision-aids/lung-cancer-screening/patient/ . Accessed May 27, 2016
    PubMed
  • 52 ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT). American College of Radiology website: http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/LungScreening.pdf . Accessed May 27, 2016
    PubMed
  • 53 http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/LungRADS/AssessmentCategories.pdf . Accessed May 27, 2016
    PubMed
  • 54 Pinsky PF, Gierada DS, Black W , et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 2015; 162 (7) 485-491
    CrossrefPubMedGoogle Scholar
  • 55 McWilliams A, Tammemagi MC, Mayo JR , et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013; 369 (10) 910-919
    CrossrefPubMedGoogle Scholar
  • 56 Haugen BR, Alexander EK, Bible KC , et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26 (1) 1-133
    CrossrefPubMedGoogle Scholar
  • 57 https://www.aace.com/files/adrenal-guidelines.pdf . Accessed May 27, 2016
    PubMed
  • 58 Chiles C, Duan F, Gladish GW , et al; NLST Study Team. Association of coronary artery calcification and mortality in the National Lung Screening Trial: a comparison of three scoring methods. Radiology 2015; 276 (1) 82-90
    CrossrefPubMedGoogle Scholar
  • 59 Htwe Y, Cham MD, Henschke CI , et al. Coronary artery calcification on low-dose computed tomography: comparison of Agatston and Ordinal Scores. Clin Imaging 2015; 39 (5) 799-802
    CrossrefPubMedGoogle Scholar
  • 60 https://my.americanheart.org/idc/groups/ahaecc-internal/@wcm/@sop/documents/downloadable/ucm_423806.pdf . Accessed May 27, 2016
    PubMed
  • 61 Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321 (7257) 323-329
    CrossrefPubMedGoogle Scholar
  • 62 Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force. Ann Am Thorac Soc 2014; 11 (4) 619-627
    PubMedGoogle Scholar